ASCO: Early Purple Biotech data gain ground in metastatic pancreatic cancer fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.
Scopus BioPharma soars on FDA approval
At one stage in yesterday s session, Scopus Biopharma s share price was up 100%. It closed up nearly 80%.
Drug company Scopus BioPharma Inc. (Nasdaq: SCPS), has reported that the US Food and Drug Administration (FDA) has approved the start of a clinical trial for the company s RNA cancer therapy (CpG-STAT3siRNA), developed in cooperation with the City of Hope hospital in California. A Phase 1 clinical trial for B-cell non-Hodgkin lymphoma will be initiated at City of Hope.
At one stage in yesterday s session, Scopus Biopharma s share price was up 100%. It closed up nearly 80%.
Scopus BioPharma has an Israeli connection in that one of its founders, Dr. Morris Laster is an American-Israeli. Laster has over 30 years experience in the drugs industry, and in the past he founded, or co-founded, and managed companies such as BioLineRx Ltd. (Nasdaq: BLRX), Keryx Biopharmaceuticals, merged in December 2018 with Akebia Therapeutics, Inc. (Nasdaq: AKB
Penny Stocks To Buy According To Analysts
Whether you love penny stocks or hate them, you canât argue with the fact that big money can be made. By definition, the term itself references stocks to buy for less than $5. So even the slightest 50 cent move from the highest-priced penny stock is a near-market-beating gain.
For the most part, newer retail traders actively learn how to day trade and start by focusing on cheap stocks to watch. Since it doesnât take a whole lot of capital to buy penny stocks, theyâve become somewhat of a âgo-toâ for mom-and-pop investors. This year, in fact, has shed a lot of light on the power that these âdumb moneyâ traders can have on the stock market.